Using Pharmacogenetic Testing or Platelet Reactivity Testing to Tailor Antiplatelet Therapy: Are Asians different from Caucasians?

Abstract excerpt

All studies to date involving platelet reactivity and gene testing document singular interventions and their associations with outcomes. The East Asian paradox has been well documented - Asians who have had a percutaneous coronary intervention (PCI) are at a lower risk of ischaemic events even though they have a higher platelet reactivity. Asians who have had a PCI also have a higher risk of bleeding. This...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Myocardial Infarction Research
• Share to Antiplatelet Therapy and Cardiovascular Diseases
• Share to Coronary Interventions and Diagnostics